Exploring the common mechanism of Yindan Xinnaotong soft capsule in the treatment of stroke and coronary heart disease through HIF1α-MMP9-mediated HIF1α signaling pathway
1. College of Traditional Chinese Medicine, Hebei University, Baoding 071002, China
2. State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
3. Zunyi Medical and Pharmaceutical College, Zunyi 563000, China
4. Guizhou Bailing Group Pharmaceutical Co. Ltd., Guiyang 550000, China
5. First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
收起